With pipelines diminishing and generics becoming more aggressive, pharmaceutical companies must maximize their brands' value and time on the market. A Guidebook to Pharma Brand Optimization analyzes the inner-workings of lifecycle management strategy, development and implementation processes.
Nov. 19POPLARVILLE Dr. James M. Riser said on Wednesday that about 500 school students here were vaccinated on Monday and Tuesday by health care officials, and that an additional round of vaccinations is planned for Dec. 14 to give students here another chance to get the swine flu shot. "We had hoped for at least 1,000, but it was still very s
A new company called the Emirates Biotech Pharmaceutical Factory LLC has been come up in the capital, which will set up new facilities to produce pharmaceuticals and raw materials based on biotechnology process. The products to be produced include crystal insulin for diabetes, anti-cancers, vaccines, haemophilia A and growth factors.
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is this week celebrating its 10th anniversary of providing central laboratory services throughout Europe.
3M Skin & Wound Care Division announced that the American Medical Association has created a new Category I Current Procedural Terminology (CPT) code that will describe the application of 3M Coban 2 Layer Compression System; CPT code 29581 - "Application of multi-layer venous wound compression system, below the knee."
Dublin - Research and Markets has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry" report to their offering. A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use.
11/20/09 ZoomMed Inc., creator of the ZRx Prescriber, the e-Pic communication network and the ZRx Pharma communication network announced during its shareholders meeting held today 10:00 am, the signing new contracts with pharmaceutical companies and the official launch of its e-Pic to pharmacies network. $1,482,500 in pharmaceutical contracts du
Antares Pharma, Inc. announced that it will release its third quarter 2009 financial results after the market closes on Monday, November 9, 2009, and host a conference call shortly thereafter at 4:30 PM to discuss the results. Interested parties may participate in the conference call by dialing 1-800-762-8908, or 480-629-9774, 5-10 minutes prior
LEXINGTON, Mass.-Biotechnology company Antigenics Inc. said Friday it will not seek approval for a potential kidney cancer treatment after a European advisory committee recommended against approving the drug candidate. The Committee for Medicinal Products for Human Use of The European Medicines Agency gave a negative opinion on the kidney cancer tr
Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma Inc, one of the world's top 20 pharmaceutical companies, can announce details of an Astellas Changing Tomorrow Charity Award for the International Foundation for Dermatology. The Astellas Changing Tomorrow Charity Awards complement the company's existing ongoing Corpo
AstraZeneca and the Philadelphia Department of Public Health announced today at a press conference at Philadelphia Health Care Center #6 that AstraZeneca will provide free medicines to the city's Health Centers to help uninsured Philadelphians access both the medical care and medications they need.
20 November 2009 - US biopharmaceutical company AVI BioPharma Inc said yesterday that data for its exon skipping therapy for Duchenne muscular dystrophy were reported at the TREAT-NMD / NIH International Conference that took place 17-19 November in Brussels, Belgium. At the conference, data from the company's clinical and preclinical programmes wer
BD today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, announced that it has closed a private placement of approximately $3.6 million worth of securities with certain accredited investors on Monday, November 2, 2009.
SRU Biosystems announced that Caliper Life Sciences will use SRU Biosystems' label-free BIND technology to offer new functional assays as part of its Discovery Alliances and Services. The label-free BIND technology, developed by SRU Biosystems, provides researchers with a new ultra-high throughput screening and profiling system for cell-based
Biopharmaceutical company Cell Therapeutics Inc said on Friday that it has won its appeal case to pursue a USD22.8m claim against The Lash Group, its former third-party reimbursement consultant for TRISENOX.
Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial.
Nov. 19County commissioner Wayne Willingham addressed West Point's town council Monday evening regarding the county's proposed Smith Lake water project. "This is a feasible proposal," Willingham said. The county's plan includes upgrading the treatment facilities at Lake Catoma and constructing a new treatment facility that would pump water from S
Complete Genomics, a third-generation human genome sequencing company, announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes.
CVS Caremark announced it has extended its contract to provide retail pharmacy benefit services and all clinical services for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program. CVS Caremark has administered FEP's retail pharmacy benefit management program since 1993.
CytRx, a biopharmaceutical company, has announced plans to initiate an open-label, multinational Phase II clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric cancer.
SAS announced that Dainippon Sumitomo Pharma America, Inc., a U.S. pharmaceutical company, has selected SAS Solutions OnDemand: Drug Development as a technology platform for clinical development. The SAS OnDemand service has allowed DSPA to move quickly, with limited internal resources, in creating its centralized SAS development environment.
According to recent research published in the Journal of Cardiovascular Pharmacology, "The effect of carperitide, recombinant human atrial natriuretic peptide, on chronic heart failure has not been clarified. "A 28-day infusion of carperitide or vehicle was administrated to the rats 4 weeks after experimental autoimmune myocarditis induction.
CVS Caremark announced the appointment of David M. Denton to the new role of Executive Vice President and Chief Financial Officer, effective January 1, 2010. Denton, currently CVS Caremark's SVP, Controller and Chief Accounting Officer, brings nearly twenty years of financial management experience with a focus on the health care and retail drug
